|
GSK
5 Moore Drive, Durham, NC 27709 nucalahcp.com About GSK GSK is a science-led global healthcare company with a special purpose: to help people. We research, develop, and manufacture innovative pharmaceutical, biological, vaccine, and consumer healthcare products in an effort to bring differentiated, high-quality products to the people who need them. Visit our virtual booth or website to learn more about our products, resources, and the science behind it all. Representative Julie Tebera julie.m.tebera@gsk.com Fritz Flanigan 412-780-5737 john.f.flanigan@gsk.com Steve Volansky 814-771-6127 stephen.a.volansky@gsk.com Abby Fitzgerald 443-306-3188 Abigail.x.fitzgerald@gsk.com Dean Sickenberger 412-558-8256 dean.e.sickenberger@gsk.com Debbie Dunay 570-690-6855 Deborah.a.dunay@gsk.com |
Representatives will be available to meet with attendees at the following times:
Meeting ID: 869 1239 4285
Passcode: iWkm1?X6 
Severe Eosinophilic Asthma | NUCALA (mepolizumab) for HCPs
nucalahcp.com |
Join Us for a Virtual ISS Program
Friday, June 25 at 1:30 p.m.
Clinical Evidence for Patient Selection and Management of Severe Eosinophilic Asthma with a Biologic
Speaker: Lawrence Dubuske, MD
Register to Attend!
To register for the program, click here below and select "Clinical Evidence on Patient Selection and Management of Severe Eosinophilic Asthma With a Biologic" on June 25 at 1:30pm from the list of events.
Friday, June 25 at 1:30 p.m.
Clinical Evidence for Patient Selection and Management of Severe Eosinophilic Asthma with a Biologic
Speaker: Lawrence Dubuske, MD
Register to Attend!
To register for the program, click here below and select "Clinical Evidence on Patient Selection and Management of Severe Eosinophilic Asthma With a Biologic" on June 25 at 1:30pm from the list of events.
